BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33577837)

  • 1. Synergistic potential of dual andrographolide and melatonin targeting of metastatic colon cancer cells: Using the Chou-Talalay combination index method.
    Banerjee V; Sharda N; Huse J; Singh D; Sokolov D; Czinn SJ; Blanchard TG; Banerjee A
    Eur J Pharmacol; 2021 Apr; 897():173919. PubMed ID: 33577837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin and andrographolide synergize to inhibit the colospheroid phenotype by targeting Wnt/beta-catenin signaling.
    Sokolov D; Sharda N; Giri B; Hassan MS; Singh D; Tarasiewicz A; Lohr C; von Holzen U; Kristian T; Waddell J; Reiter RJ; Ahmed H; Banerjee A
    J Pineal Res; 2022 Aug; 73(1):e12808. PubMed ID: 35619550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Andrographolide and Melatonin Combinatorial Drug Therapy on Metastatic Colon Cancer Cells and Organoids.
    Sharda N; Ikuse T; Hill E; Garcia S; Czinn SJ; Bafford A; Blanchard TG; Banerjee A
    Clin Med Insights Oncol; 2021; 15():11795549211012672. PubMed ID: 34158803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs.
    Duarte D; Cardoso A; Vale N
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum stress and IRE-1 signaling cause apoptosis in colon cancer cells in response to andrographolide treatment.
    Banerjee A; Ahmed H; Yang P; Czinn SJ; Blanchard TG
    Oncotarget; 2016 Jul; 7(27):41432-41444. PubMed ID: 27166181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression.
    Wang W; Guo W; Li L; Fu Z; Liu W; Gao J; Shu Y; Xu Q; Sun Y; Gu Y
    Biochem Pharmacol; 2016 Dec; 121():8-17. PubMed ID: 27693317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method.
    Zhang N; Fu JN; Chou TC
    Am J Cancer Res; 2016; 6(1):97-104. PubMed ID: 27073727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells.
    Ju SY; Huang CY; Huang WC; Su Y
    Cell Death Dis; 2015 Jul; 6(7):e1801. PubMed ID: 26136074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells.
    Banerjee A; Banerjee V; Czinn S; Blanchard T
    Oncotarget; 2017 Apr; 8(16):26142-26153. PubMed ID: 28412728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Andrographolide Exhibits Anticancer Potential Against Human Colon Cancer Cells by Inducing Cell Cycle Arrest and Programmed Cell Death via Augmentation of Intracellular Reactive Oxygen Species Level.
    Khan I; Khan F; Farooqui A; Ansari IA
    Nutr Cancer; 2018 Jul; 70(5):787-803. PubMed ID: 29781715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Interaction of CPP2 Coupled with Thiazole Derivates Combined with Clotrimazole and Antineoplastic Drugs in Prostate and Colon Cancer Cell Lines.
    Duarte D; Vale N
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schedule-dependent synergism between raltitrexed and irinotecan in human colon cancer cells in vitro.
    Aschele C; Baldo C; Sobrero AF; Debernardis D; Bornmann WG; Bertino JR
    Clin Cancer Res; 1998 May; 4(5):1323-30. PubMed ID: 9607593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.
    Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P
    Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracil.
    Kotlarz A; Przybyszewska M; Swoboda P; Miłoszewska J; Grygorowicz MA; Kutner A; Markowicz S
    Tumour Biol; 2016 Apr; 37(4):4699-709. PubMed ID: 26511971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
    Okada K; Hakata S; Terashima J; Gamou T; Habano W; Ozawa S
    Oncol Rep; 2016 Oct; 36(4):1875-85. PubMed ID: 27509880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer.
    Reabroi S; Chairoungdua A; Saeeng R; Kasemsuk T; Saengsawang W; Zhu W; Piyachaturawat P
    Biomed Pharmacother; 2018 May; 101():414-421. PubMed ID: 29501763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosis.
    Zou H; Li L; Garcia Carcedo I; Xu ZP; Monteiro M; Gu W
    Int J Nanomedicine; 2016; 11():1947-58. PubMed ID: 27226714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of RASSF1A in Colon Cancer by Suppression of Angiogenesis Signaling and Akt Activation.
    Blanchard TG; Lapidus R; Banerjee V; Bafford AC; Czinn SJ; Ahmed H; Banerjee A
    Cell Physiol Biochem; 2018; 48(3):1259-1273. PubMed ID: 30045022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells.
    Nair S; Hebbar V; Shen G; Gopalakrishnan A; Khor TO; Yu S; Xu C; Kong AN
    Pharm Res; 2008 Feb; 25(2):387-99. PubMed ID: 17657594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.
    Gao Y; Xiao X; Zhang C; Yu W; Guo W; Zhang Z; Li Z; Feng X; Hao J; Zhang K; Xiao B; Chen M; Huang W; Xiong S; Wu X; Deng W
    J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 27865009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.